12.1
Edesa Biotech, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
9.09
FY23:
6.44
FY24:
1.68
FY25:
11.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.49
FY22:
2.48
FY23:
2.45
FY24:
2.14
FY25:
2.02
Total assets
Change from FY21 to FY25
millions USD
FY21:
14.6
FY22:
11.6
FY23:
8.89
FY24:
3.81
FY25:
13.5
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.46
FY22:
2.14
FY23:
1.82
FY24:
1.83
FY25:
1.08
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.07
FY22:
0.04
FY23:
0.02
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
13.1
FY22:
9.39
FY23:
7.05
FY24:
1.98
FY25:
12.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
14.6
FY22:
11.6
FY23:
8.89
FY24:
3.81
FY25:
13.5
All amounts in millions USD